UBS Group’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.91M | Buy |
1,604,090
+214,497
| +15% | +$430K | ﹤0.01% | 4321 |
|
|
2025
Q4 | $1.9M | Sell |
1,389,593
-2,181,564
| -61% | -$2.88M | ﹤0.01% | 5026 |
|
|
2025
Q3 | $4.43M | Buy |
3,571,157
+1,532,238
| +75% | +$1.83M | ﹤0.01% | 4157 |
|
|
2025
Q2 | $2.3M | Sell |
2,038,919
-104,191
| -5% | -$138K | ﹤0.01% | 4664 |
|
|
2025
Q1 | $3.13M | Buy |
2,143,110
+1,346,619
| +169% | +$2.54M | ﹤0.01% | 4272 |
|
|
2024
Q4 | $1.7M | Buy |
796,491
+449,151
| +129% | +$1.11M | ﹤0.01% | 4886 |
|
|
2024
Q3 | $973K | Buy |
347,340
+47,019
| +16% | +$125K | ﹤0.01% | 4682 |
|
|
2024
Q2 | $700K | Sell |
300,321
-218,880
| -42% | -$646K | ﹤0.01% | 4736 |
|
|
2024
Q1 | $2.32M | Buy |
519,201
+338,006
| +187% | +$1.41M | ﹤0.01% | 3795 |
|
|
2023
Q4 | $582K | Sell |
181,195
-25,564
| -12% | -$72.5K | ﹤0.01% | 4986 |
|
|
2023
Q3 | $655K | Sell |
206,759
-90,253
| -30% | -$396K | ﹤0.01% | 4444 |
|
|
2023
Q2 | $1.48M | Buy |
297,012
+64,501
| +28% | +$349K | ﹤0.01% | 3838 |
|
|
2023
Q1 | $1.15M | Buy |
232,511
+96,631
| +71% | +$620K | ﹤0.01% | 3986 |
|
|
2022
Q4 | $855K | Sell |
135,880
-45,596
| -25% | -$422K | ﹤0.01% | 4225 |
|
|
2022
Q3 | $1.96M | Buy |
181,476
+44,207
| +32% | +$601K | ﹤0.01% | 3181 |
|
|
2022
Q2 | $1.56M | Sell |
137,269
-85,598
| -38% | -$760K | ﹤0.01% | 3346 |
|
|
2022
Q1 | $2.03M | Buy |
222,867
+65,126
| +41% | +$678K | ﹤0.01% | 3406 |
|
|
2021
Q4 | $2.35M | Sell |
157,741
-14,769
| -9% | -$261K | ﹤0.01% | 3581 |
|
|
2021
Q3 | $4.43M | Buy |
172,510
+134,161
| +350% | +$3.19M | ﹤0.01% | 2796 |
|
|
2021
Q2 | $1M | Sell |
38,349
-47,409
| -55% | -$1.35M | ﹤0.01% | 4175 |
|
|
2021
Q1 | $3.03M | Buy |
85,758
+84,515
| +6,799% | +$2.85M | ﹤0.01% | 3135 |
|
|
2020
Q4 | $32K | Sell |
1,243
-199
| -14% | -$6.49K | ﹤0.01% | 6569 |
|
|
2020
Q3 | $54K | Sell |
1,442
-1,537
| -52% | -$57.9K | ﹤0.01% | 5589 |
|
|
2020
Q2 | $128K | Sell |
2,979
-174
| -6% | -$6.29K | ﹤0.01% | 5115 |
|
|
2020
Q1 | $62K | Buy |
3,153
+831
| +36% | +$19.8K | ﹤0.01% | 5649 |
|
|
2019
Q4 | $60K | Sell |
2,322
-1,605
| -41% | -$44.2K | ﹤0.01% | 6250 |
|
|
2019
Q3 | $107K | Sell |
3,927
-56,758
| -94% | -$1.62M | ﹤0.01% | 5733 |
|
|
2019
Q2 | $1.63M | Buy |
60,685
+51,427
| +555% | +$1.43M | ﹤0.01% | 3334 |
|
|
2019
Q1 | $268K | Buy |
9,258
+6,236
| +206% | +$181K | ﹤0.01% | 4428 |
|
|
2018
Q4 | $81K | Buy |
+3,022
| New | +$80.3K | ﹤0.01% | 5714 |
|
Other funds holding ALLO
P
TGA
VCM
